Clinical trial
LENUS Pro® Study (LPS-II) - Observation Study With Implantable Medication Pump for Intravenous REMODULIN® (Treprostinil) Therapy in Patients With Pulmonary Arterial Hypertension
NCT04309838 is registered in ClinicalTrials.gov with University Medicine Greifswald as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- LENUS Pro® Study (LPS-II) - Observation Study With Implantable Medication Pump for Intravenous REMODULIN® (Treprostinil) Therapy in Patients With Pulmonary Arterial Hypertension
- Lead sponsor
- University Medicine Greifswald
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- March 31, 2020
- Completion date
- December 31, 2021
- Enrollment
- 30 (estimated)
- Sites
- 8
Conditions
As the registry lists them; a condition with its own page is linked.